Strategic Partnerships Bristol-Myers Squibb Co has been actively forming partnerships such as the one with Share My Meals Inc., indicating potential collaboration opportunities with organizations aligned with social causes.
Technology Adoption The company's tech stack includes Google Analytics, Oracle Business Intelligence, and LinkedIn, highlighting a focus on data-driven decision-making and potential partnerships with technology solution providers.
Competitive Positioning With a revenue range of $50M - 100M, Mirati Therapeutics competes with similar companies like Blueprint Medicines and Turning Point Therapeutics, presenting a target market for comparative product offerings.
Recent Awards and Recognitions Bristol-Myers Squibb Co's recognition with the Brandon Hall Gold Award for Best Executive Development Program positions them as an industry leader, indicating potential sales opportunities to provide similar development programs to other companies.
Market Expansion The recent launch of the 2023 ESG Report and partnership with Agenus demonstrate a focus on sustainability and collaborative research, signaling potential sales opportunities in the growing ESG and biotech sectors.
732
$100M$1B
201$50M$100M
11
413$50M$100M
114$10M$50M
145$10M$50M
192$10M$50M
966$100M$1B
66
459$50M$100MMirati Therapeutics uses 8 technology products and services including Google Analytics, Oracle Business Intelligence, OpenStack, and more. Explore Mirati Therapeutics's tech stack below.
| Mirati Therapeutics Email Formats | Percentage |
| LastF@mirati.com | 89% |
| FLast@mirati.com | 4% |
| Last@mirati.com | 4% |
| First@mirati.com | 1% |
| FirstL@mirati.com | 1% |
| LastFir@mirati.com | 1% |
| First.Last@bms.com | 95% |
| LastF@bms.com | 2% |
| Last.First@bms.com | 2% |
| First.Middle@bms.com | 1% |
Biotechnology ResearchCalifornia, United States201-500 Employees
Mirati Therapeutics, Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies that target the genetic drivers of cancer @Bristol Myers Squibb or www.bms.com
Company Overview
Funding & FinancialsMirati Therapeutics has raised a total of $345M of funding over 8 rounds. Their latest funding round was raised on Aug 09, 2023 in the amount of $345M.
Mirati Therapeutics's revenue is in the range of $50M$100M
Funding & FinancialsMirati Therapeutics has raised a total of $345M of funding over 8 rounds. Their latest funding round was raised on Aug 09, 2023 in the amount of $345M.
Mirati Therapeutics's revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com